Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
0.6900
0.00 (0.00%)
At close: Jun 17, 2026, 4:00 PM EDT
0.7000
+0.0100 (1.45%)
After-hours: Jun 17, 2026, 7:55 PM EDT
Vistagen Therapeutics Market Cap
Vistagen Therapeutics has a market cap or net worth of $27.34 million as of June 17, 2026. Its market cap has decreased by -60.38% in one year.
Market Cap
27.34M
Enterprise Value
-33.00M
1-Year Change
-60.38%
Ranking
Category
Stock Price
$0.69
Market Cap Chart
Since May 11, 2016, Vistagen Therapeutics's market cap has increased from $9.30M to $27.34M, an increase of 193.96%. That is a compound annual growth rate of 11.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 28.30M | 8.43% |
| Dec 31, 2025 | 26.10M | -68.21% |
| Dec 31, 2024 | 82.10M | -40.89% |
| Dec 29, 2023 | 138.90M | 552.11% |
| Dec 30, 2022 | 21.30M | -94.53% |
| Dec 31, 2021 | 389.40M | 171.17% |
| Dec 31, 2020 | 143.60M | 381.88% |
| Dec 31, 2019 | 29.80M | -36.05% |
| Dec 31, 2018 | 46.60M | 258.46% |
| Dec 29, 2017 | 13.00M | -58.47% |
| Dec 30, 2016 | 31.30M | 236.56% |
| May 11, 2016 | 9.30M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Apollomics | 30.04M |
| Plus Therapeutics | 29.67M |
| Senti Biosciences Holdings | 29.61M |
| Serina Therapeutics | 29.50M |
| Barinthus Biotherapeutics | 28.53M |
| Kyntra Bio | 27.97M |
| Evaxion | 27.69M |
| IGC Pharma | 27.24M |